USA flag logo/image

An Official Website of the United States Government

Biological Decontamination for Forward-Deployed Airbase Using Low Temperature…

Award Information

Agency:
Department of Defense
Branch:
Air Force
Award ID:
56037
Program Year/Program:
2002 / STTR
Agency Tracking Number:
F023-0084
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
ASI TECHNOLOGY CORP.
980 American Pacific Drive, Suite 111 Henderson, NV 89014
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 2002
Title: Biological Decontamination for Forward-Deployed Airbase Using Low Temperature Air Plasmas
Agency / Branch: DOD / USAF
Contract: F49620-02-C-0052
Award Amount: $99,333.00
 

Abstract:

"ASI's plasma consultant, Igor Alexeff, PhD, has invented, tested and patented an atmospheric pressure, dc of 60 Hz AC discharge, that has been operated in air, helium, argon and nitrogen. The apparatus has in laboratory testing successfully destroyedmicroorganisms. The apparatus does not require a complicated, fragile RF power supply for operation. We propose it to be developed into equipment for decontamination of bioterror materials in the field. The device works well with a simple 60 Hz. Neontransformer. The electrodes are made of unglazed ceramic. The ion density has been measured to be 10 exp 12 per cc. Power consumption used was 300 watts to create several liters of helium plasma. In order to carry out the proposed Air Force program ofidentifying and evaluating the biologically active species present in the discharge, we propose employing new sensors that can unambiguously detect and measure the concentration of O2, NO and NO2, ultraviolet light, charged ions, and metastable atoms. Inaddition, we will evaluate methods of producing each species separately. The isolation of each species will be used in the biological studies planned in Phase II to identify which species is effective in biological decontamination. The methodology andapparatus proposed by ASI could revolutionize sterilization techniques throughout the civilian and military communities, if successfully commercialized. The commercial market for safer atmospheric plasma decontamination is quite large. Sepsis is the majorpost-operative cause of death in American hospitals. "

Principal Investigator:

Theodore Anderson
Researcher
7027341888
AnderDrTed@aol.com

Business Contact:

Jerry E. Polis
President
7027341888
jerrypolis@aol.com
Small Business Information at Submission:

Asi Technology Corp.
980 American Pacific Drive, Suite 111 Henderson, NV 89014

EIN/Tax ID: 880105586
DUNS: N/A
Number of Employees:
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
Research Institution Information:
Eastern Virginia Medical School
Department of Pediatrics, 855 W. Brambleton Ave.
Norfolk, VA 23510
Contact: Stephen Beebe, Phd
Contact Phone: (757) 668-6465
RI Type: Nonprofit college or university